Form 4: Nasdaq Director Thomas Kloet Reports Stock Acquisition
SEC Form 4 Filing
Director Thomas Kloet reports acquisition of Nasdaq shares, including restricted stock vesting and shares held in a family trust.
Summary
- On June 11, 2024, Thomas A. Kloet, a director of Nasdaq, Inc., acquired 6,522 shares of common stock.
- These shares were acquired as restricted stock, vesting 100% on June 11, 2025.
- Following the transaction, Kloet directly owns 27,456 shares and indirectly owns 68,709 shares through a family trust.
- The direct holdings include 21,456 shares of restricted stock granted pursuant to Nasdaq's Equity Incentive Plan, with 7,320 shares already vested, and 6,000 shares acquired through open market purchases.
- The shares held in the Thomas A. Kloet Trust are those for which the reporting person is trustee and beneficiary.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard regulatory filing detailing stock transactions. The acquisition of shares by a director is generally viewed positively, but the document itself is purely informational.
Positives
- The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future performance.
- The vesting of restricted stock aligns the director's interests with those of the shareholders.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting of restricted stock in the future suggests a continued alignment of the director's interests with the company's performance.
Industry Context
Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. This filing is a routine disclosure required by the SEC.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their insiders.
- The reporting requirements are consistent across all companies listed on U.S. exchanges, including Nasdaq's competitors like Intercontinental Exchange (ICE) and CME Group.
Stakeholder Impact
- The transaction may have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.
Key Dates
| Date | Description |
|---|---|
| 06/11/2024 | Date of stock acquisition and grant of restricted stock. |
| 06/11/2025 | Date when the restricted stock vests 100%. |
| 06/13/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.